RXI PHARMACEUTICALS Aktie

0,86 EUR -86,2400%

Zu Ihrem Onlinebroker

kaufen verkaufen

RXI PHARMACEUTICALS Aktienkurs : 04.04. ( 15 Min. verzögert)
0,860 € Letzter Kurs	-86,24% Veränderung	6,25 € Vortag	0,860 € Eröffnungskurs

Realtime:

0,86

-86,24%

mehr Informationen

Hoch/Tief		Volumen		Geldkurs	Briefkurs
0,860 - 0,860 Tag	0,860 - 0,860 52 Wochen	350 Tag	350 Ø 52 Wochen	0,0000000 0 Stücke	0,0000000 0 Stücke

RXI PHARMACEUTICALS Aktienkurs

Wollen Sie wissen, wie es mit dieser Aktie weitergeht?
Wir informieren Sie kostenlos.

Erhalten Sie außerdem Expertenanalysen von:
Gevestor Täglich und John Gossens Daily DAX

23.05.

Three Stocks Not Getting Crushed by the Marketwide Selloff: HYSR, BIEL, GALE

GALE was formerly RXi Pharmaceuticals Corporation - a biotech stock with a focus on oncology, working on a drug called NeuVax. That's not changed. The...
21.05.

Biotech Industry Booming in 2012

The company completed a partial spin-off of RXi Pharmaceuticals Corporation. RXi is now operating as an independent, publicly-traded company. A one-for-one dividend of RXi common stock was recently paid...

17.05.

Under New Management, RXi Takes Aim at the Clinic, Wall Street

By Doug Macron Following RXi Pharmaceuticals' successful spinout of Galena Biopharma, RXi's newly appointed CEO sees advancing the anti-scarring drug candidate RXI-109 into human testing as...
14.05.

Galena Biopharma Reports First Quarter 2012 Financial Results

Completed partial spin-off of RXi Pharmaceuticals Corporation. RXi is now operating as an independent, publicly-traded company. A one-for-one dividend of RXi common stock was recently paid...
14.05.

Galena Biopharma Reports First Quarter 2012 Financial Results

Completed partial spin-off of RXi Pharmaceuticals Corporation. RXi is now operating as an independent, publicly-traded company. A one-for-one dividend of RXi common stock was recently paid...